Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Mesa Laboratories Inc (MLAB)  
$103.19 1.39 (1.37%) as of 4:30 Fri 4/26


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 5,524,000
Market Cap: 570.02(M)
Last Volume: 19,542 Avg Vol: 40,496
52 Week Range: $84.55 - $168.51
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:

    NASDAQ COMPOSITE     NASDAQ INDUSTRIAL
    NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Mesa Laboratories manufactures, develops, and sells quality control products and services. Co. is organized into four segments: Sterilization and Disinfection Control Division, which provides manufactures and sells biological, chemical and cleaning indicators used to assess the effectiveness of sterilization processes; Biopharmaceutical Development Division, which develops, manufactures, and sells automated systems for protein analysis and peptide synthesis; Calibration Solutions Division, which develops, manufactures, and sells quality control and calibration products; and Clinical Genomics Division, which develops, manufactures, and sells genetic analysis tools used by labs.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 500
Total Buy Value $0 $0 $0 $100,000
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 0 1,500 10,500 46,373
Total Sell Value $0 $168,540 $1,317,035 $8,243,267
Total People Sold 0 1 3 8
Total Sell Transactions 0 1 5 25
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 176
  Page 5 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Guillemin Evan Director   –       •      –    2021-05-17 4 AS $244.25 $175,860 D/D (720) 30,595 30%     
   Sullivan John James Director   –       •      –    2021-05-13 4 GA $0.00 $0 I/I 6,436 30,000     -
   Sullivan John James Director   –       •      –    2021-05-13 4 GD $0.00 $0 D/D 6,436 26,423     -
   Sullivan John James Director   –       •      –    2021-05-06 4 AS $250.05 $50,010 D/D (200) 32,859 19%     
   Sullivan John James Director   –       •      –    2021-05-05 4 AS $250.59 $25,059 D/D (100) 33,059 21%     
   Sullivan John James Director   –       •      –    2021-05-04 4 AS $250.14 $183,853 D/D (735) 33,159 12%     
   Guillemin Evan Director   –       •      –    2021-04-16 4 AS $253.77 $182,714 D/D (720) 31,315 6%     
   Sullivan John James Director   –       •      –    2021-04-05 4/A AS $250.76 $125,380 D/D (500) 33,894     -
   Sullivan John James Director   –       •      –    2021-03-26 4 GA $0.00 $0 I/I 23,564 23,564     -
   Sullivan John James Director   –       •      –    2021-03-26 4 GD $0.00 $0 D/D 23,564 34,394     -
   Guillemin Evan Director   –       •      –    2021-03-16 4 AS $269.48 $194,026 D/D (720) 32,035 7%     
   Sakys John V CFO   •       –      –    2021-03-12 4 S $263.84 $659,600 D/D (2,500) 4,350 -6%     
   Sakys John V CFO   •       –      –    2021-03-12 4 OE $48.72 $165,480 D/D 2,500 6,850     -
   Archbold Brian David SVP Continuous Improvement   •       –      –    2021-03-11 4 OE $129.10 $18,720 D/D 145 377     -
   Archbold Brian David SVP Continuous Improvement   •       –      –    2021-03-10 4 S $271.78 $60,607 D/D (223) 154 -6%     
   Sullivan John James Director   –       •      –    2021-03-01 4 AS $273.94 $342,425 D/D (1,250) 57,958 0%     
   Dinoia Gregory SVP Commericial   •       –      –    2021-02-23 4 S $276.75 $77,490 D/D (280) 840 2%     
   Guillemin Evan Director   –       •      –    2021-02-16 4 AS $281.52 $1,013,472 D/D (3,600) 32,755 -1%     
   Schmieder John Bradley Director   –       •      –    2021-02-10 4 AS $278.23 $486,903 D/D (1,750) 71,717 -6%     
   Sullivan John James Director   –       •      –    2021-02-01 4 AS $277.67 $347,088 D/D (1,250) 59,208 -5%     
   Schmieder John Bradley Director   –       •      –    2021-01-12 4 AS $285.23 $136,055 D/D (477) 73,467 -17%     
   Sakys John V CFO   •       –      –    2021-01-08 4 OE $89.70 $89,700 D/D 1,000 4,350     -
   Sakys John V CFO   •       –      –    2021-01-06 4 AS $290.00 $4,640 D/D (16) 3,350 -15%     
   Sakys John V CFO   •       –      –    2021-01-06 4 OE $89.70 $1,435 D/D 16 3,366     -
   Kelly David M Director   –       •      –    2020-12-11 4 S $283.18 $70,795 D/D (250) 2,350 8%     

  176 Records found
  1  2  3  4  5  6  7  8   
  Page 5 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed